Berberine is the main pharmacologically active component of C. chinensis is involved in the regulation of P450 gene expression, which can also improve the chronic inflammatory state of type 2 diabetes mellitus, change or stimulate the transformation of brown adipose tissue to white, promote energy metabolism, improve insulin resistance and improve glucose metabolism (24, –, 26). Here, CYP2B6 is linked to type 2 diabetes mellitus.